RVX Therapeutics Inc.

City:

Calgary

Country:

Canada

Published Applications:

Last publication date:

2014-06-26

Patent Grants:

Last grant date:

2016-03-01

Top Inventors for applications by RVX Therapeutics Inc.

These are the the leading inventors for applications assigned to RVX Therapeutics Inc.:

Peter Ronald Young 4 San Francisco, CA United States
Kevin G. McLure 4 Calgary, Canada
Bryan Cordell Duffy 3 Glenmont, NY United States
Peter R. Young 3 San Francisco, CA United States

Gregory Scott Martin 3 Colonie, NY United States
John Frederick Quinn 3 Albany, NY United States
David John Fairfax 2 Slingerlands, NY United States
Shuang LIU 2 Schenectady, NY United States

Gregory Steven Wagner 2 Foster City, CA United States
Ruifang Wang 1 Schenectady, NY United States
Bruce Francis Molino 1 Slingerlands, NY United States
He Zhao 1 Madison, CT United States

May Xiaowu Jiang 1 Guilderland, NY United States

Recent patent applications by RVX Therapeutics Inc.

RVX Therapeutics Inc. based in Calgary, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-06-26 ✅ Patent 9,271,978 granted on 2016-03-01

US20140179648A1

Human necessities

Heterocyclic compounds as bromodomain inhibitors

#2 | 2014-05-22 ✅ Patent 9,073,878 granted on 2015-07-07

US20140142102A1

Chemistry; metallurgy

Cyclic amines as bromodomain inhibitors

#3 | 2014-05-22 ✅ Patent 9,765,039 granted on 2017-09-19

US20140140956A1

Chemistry; metallurgy

Biaryl derivatives as bromodomain inhibitors

#4 | 2013-10-24

US20130281399A1

Chemistry; metallurgy

TREATMENT OF DISEASES BY EPIGENETIC REGULATION

#5 | 2013-10-24

US20130281398A1

Chemistry; metallurgy

TREATMENT OF DISEASES BY EPIGENETIC REGULATION

#6 | 2013-10-24

US20130281397A1

Human necessities

TREATMENT OF DISEASES BY EPIGENETIC REGULATION

#7 | 2013-10-24

US20130281396A1

Chemistry; metallurgy

TREATMENT OF DISEASES BY EPIGENETIC REGULATION

AssigneeID:

43428 ⎘